| Dr Wilson M Parry, MD | |
|
1502 S Colorado St, Greenville, MS 38703-7219 | |
| (662) 335-4105 | |
| (662) 378-2879 |
| Full Name | Dr Wilson M Parry |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 36 Years |
| Location | 1502 S Colorado St, Greenville, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124188347 | NPI | - | NPPES |
| 3021392895 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 13554 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rcg Greenville | Greenville, MS | Dialysis facility |
| Rcg Cleveland | Cleveland, MS | Dialysis facility |
| Rcg Clarksdale | Clarksdale, MS | Dialysis facility |
| Bio-medical Applications Of Mississippi, Inc | Greenville, MS | Dialysis facility |
| Fmcna - Helena | Helena, AR | Dialysis facility |
| Grace Community Hospice | Cleveland, MS | Hospice |
| Delta Regional Medical Center | Greenville, MS | Hospital |
| Bolivar Medical Center | Cleveland, MS | Hospital |
| Greenwood Leflore Hospital | Greenwood, MS | Hospital |
| Chicot Memorial Medical Center | Lake village, AR | Hospital |
| North Sunflower Medical Center Cah | Ruleville, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Delta Kidney Alliance Llc | 3870834856 | 2 |
| Delta Kidney Alliance Llc | 3870834856 | 2 |
News Archive
The number of children admitted to hospital in England for acute throat infections increased by 76 per cent between 1999 and 2010, according to new research published today in Archives of Disease in Childhood.
CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces new worldwide data with its technology was presented during the scientific sessions at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA last month.
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
In a study published in this week's PLoS Medicine, "Francesca Celletti from the WHO, Geneva, Switzerland, and colleagues argue that a transformation in the scale-up of medical education in low- and middle-income countries is needed," according to a PLoS press release.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
› Verified 9 days ago
| Entity Name | Tunica County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245360148 PECOS PAC ID: 6608898499 Enrollment ID: O20051221000245 |
News Archive
The number of children admitted to hospital in England for acute throat infections increased by 76 per cent between 1999 and 2010, according to new research published today in Archives of Disease in Childhood.
CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces new worldwide data with its technology was presented during the scientific sessions at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA last month.
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
In a study published in this week's PLoS Medicine, "Francesca Celletti from the WHO, Geneva, Switzerland, and colleagues argue that a transformation in the scale-up of medical education in low- and middle-income countries is needed," according to a PLoS press release.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
› Verified 9 days ago
| Entity Name | Delta Kidney Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992276851 PECOS PAC ID: 3870834856 Enrollment ID: O20190402000570 |
News Archive
The number of children admitted to hospital in England for acute throat infections increased by 76 per cent between 1999 and 2010, according to new research published today in Archives of Disease in Childhood.
CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces new worldwide data with its technology was presented during the scientific sessions at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA last month.
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
In a study published in this week's PLoS Medicine, "Francesca Celletti from the WHO, Geneva, Switzerland, and colleagues argue that a transformation in the scale-up of medical education in low- and middle-income countries is needed," according to a PLoS press release.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wilson M Parry, MD 1502 S Colorado St, Greenville, MS 38703-7219 Ph: (662) 335-4105 | Dr Wilson M Parry, MD 1502 S Colorado St, Greenville, MS 38703-7219 Ph: (662) 335-4105 |
News Archive
The number of children admitted to hospital in England for acute throat infections increased by 76 per cent between 1999 and 2010, according to new research published today in Archives of Disease in Childhood.
CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces new worldwide data with its technology was presented during the scientific sessions at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA last month.
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
In a study published in this week's PLoS Medicine, "Francesca Celletti from the WHO, Geneva, Switzerland, and colleagues argue that a transformation in the scale-up of medical education in low- and middle-income countries is needed," according to a PLoS press release.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
› Verified 9 days ago
Nouhad O Kronfol, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1997 Medical Park Dr, Greenville, MS 38703 Phone: 662-335-4105 Fax: 662-378-2879 | |
Deepali Ramdas Kale, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 344 Arnold Ave, Greenville, MS 38701 Phone: 662-378-1311 Fax: 662-335-2001 | |
John L Herzog Sr., MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1421 E Union St, Greenville, MS 38703 Phone: 662-335-0183 Fax: 662-335-7184 | |
J Barry Gillespie, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1502 S Colorado St, Greenville, MS 38703 Phone: 662-332-9872 Fax: 662-378-0280 | |
Ravi V Patel, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1502 S Colorado St, Greenville, MS 38703 Phone: 662-335-4105 | |
Dr. Jerry Milton Cunningham, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 521 Fairview, Greenville, MS 38701 Phone: 662-334-9182 Fax: 662-335-5320 |